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Abstract
Background: Vascular remodeling generated by reactive
oxygen species contributes to aneurysm formation. The
NADPH oxidase system is a major source of superoxide
anion not only in phagocytes, but also in endothelial
and vascular smooth muscle cells. Polymorphisms of
p22phox, an essential component of the NADPH oxidase
system, are found to be associated with atherosclerosis,
while a recent study found a significant association
between the 214C1T polymorphism and the occurrence
of ischemic cerebrovascular disease. We conducted a
case-control study to investigate the relationship of five
polymorphisms of the p22phox gene and the occurrence
of cerebral aneurysms. Methods: The study population
consisted of 113 patients with intracranial aneurysms
and 53 control subjects. The 214C1T polymorphism was
investigated by restriction fragment length polymor-
phism analysis, while polymorphisms 381T1C, 480G1A,
521C1T, and *24A1G were analyzed by direct sequenc-
ing of exon 6 and adjacent intronic sequences. Results:
The analysis of a primary study sample comprising 35
cases and 28 controls failed to show a significant asso-
ciation between any of the five polymorphisms and the
occurrence of intracranial aneurysms using both allele
frequencies and genotypes (all nominal p 1 0.05). Al-
though there was a deviation from Hardy-Weinberg
equilibrium in cases at the 521C1T locus (nominal p !
0.05), this could not be confirmed in a second study sam-
ple of 78 patients. Haplotypes were constructed regard-
ing three frequent polymorphisms (214C1T, 521C1T, and
*24A1G); haplotype frequencies in cases and controls
were not significantly different. Conclusion: Although
polymorphisms of the p22phox gene located in the cod-
ing region and the 3)-untranslated region were reported
to be associated with atherosclerosis and cerebrovascu-
lar disease, our data provide evidence that there is no
association between these polymorphisms and the oc-
currence of cerebral aneurysms in Caucasians.
Copyright © 2003 S. Karger AG, Basel
Introduction
The NADPH oxidase system is an important enzymat-
ic origin of oxygen free radicals [1]. However, recent
studies have shown that the NADPH oxidase system in
nonphagocytic cells like vascular smooth muscle cells
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Table 1. Characterization of aneurysm patients
Patient characteristics Value
Male 49
Mean age, years 54.0 (range 23–75)
Female 64
Mean age, years 54.5 (range 29–72)
SAH 99
Incidental 14
Location
ACA, A.com.ant. 51
MCA 31
ICA 15
PICA 4
BA 7
Others 5
Multiple 11a
Risk factors
Former history of SAH 0
Familial history of SAH 3
Current or former smoker 38
Hypertension 32
Treatment
Clipping 76
Endovascular procedure 37
SAH = Subarachnoid hemorrhage; ACA = anterior cerebral
artery; MCA = middle cerebral artery; ICA = internal carotid artery;
PICA = posterior inferior cerebellar artery; BA = basilar artery.
a Seven patients had two aneurysms, 2 patients had three, 1 patient
had five, and 1 patient had six aneurysms.
(VSMCs) and endothelial cells is the major source of
superoxide anion [2]. p22phox is an important compo-
nent in both phagocytic and nonphagocytic NADPH oxi-
dase, forming the ·-subunit of the cytochrome b558 which
functions as the final electron transporter from NADPH
and NADH to molecular oxygen in the system [3]. Oxy-
gen free radicals in these compartments were found to be
involved in the pathogenesis of atherosclerotic vascular
disease [4, 5]. Oxidative stress is induced in the vascula-
ture by activation of redox-sensitive signaling pathways
and stimulation of VSMC mitogenesis which contributes
to atherogenesis. Remodeling of the extracellular matrix
and atherosclerotic structural changes were found in the
initial stages of intracranial aneurysm development [6, 7].
Therefore, it is reasonable to investigate the major source
of superoxide anion – the NADPH oxidase system – in
patients with intracranial aneurysms.
Four polymorphisms of the p22phox gene have been
reported in the literature, while another one, 381T1C, is
only listed in the single nucleotide polymorphism (SNP)
databank (www.ncbi.nlm.nih.gov/SNP, dbSNP: 12123).
Three of these (381T1C, 480G1A, and 521C1T) are
located in exon 6, while one, *24A1G, is located in the
3)-untranslated region (3)-UTR), and the 214C1T poly-
morphism is located in exon 4. There are controversial
results on whether the 214C1T polymorphism is associat-
ed with the occurrence of coronary artery disease [8–11].
Recently, this polymorphism was reported to be associat-
ed with the occurrence of cerebrovascular disease in a
Japanese population [12]. Our aim was to investigate
whether there is an association between the genotype and
the phenotype in intracranial aneurysms. In addition, it is
of interest to analyze the allele frequencies of these poly-
morphisms in different ethnic groups. Therefore, we in-
vestigated the allele and genotype frequencies and con-
structed haplotypes comprising five polymorphisms of
the NADPH p22phox gene in a Caucasian population
with intracranial aneurysms.
Material and Methods
Study Population
The patient group consisted of 113 unrelated, consecutively
recruited patients with intracranial aneurysms (49 males, 65 females,
mean age 54 (range 21–75) and 55 (range 27–82) years, respectively).
All patients presented with at least one aneurysm, which was con-
firmed by cerebral angiography. They were all operated on or treated
by an endovascular approach between 1997 and 1998 at the Depart-
ments of Neurosurgery and Neuroradiology, University of Technolo-
gy, Dresden. All patients were residents of the Dresden urban area.
Further details are listed in table 1.
The control groups consisted of 28 (14 male, 14 female) and 25
(13 male, 12 female) anonymous, healthy blood donors enrolled from
the same urban area.
This study was approved by the local ethics committee. Informed
written consent for genetic analysis was obtained from all patients.
Determination of 214C1T Polymorphism by Restriction
Fragment Length Polymorphism
The 214C1T polymorphism generates a RsaI digestion site.
Therefore, we decided to analyze this genomic site by restriction frag-
ment length polymorphism analysis. Genomic DNA was amplified
by polymerase chain reaction (PCR) using primers 5)-TGCTTGT-
GGGTAAACCAAGG-3) (sense), and 5)-GGAAAAACACTGAG-
GTAAGTG-3) (antisense) as previously described [11]. Both primers
were Cy5 end-labeled. PCR conditions were: 1 cycle at 94 °C for
3 min; 35 cycles of 1 min at 94 °C, 1 min at 60°C, and 1 min at
72°C, followed by final extension at 72°C for 10 min in a Gene Amp
PCR system 2400 (Perkin Elmer, Applied Biosystems GmbH, Wei-
terstadt, Germany).
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Fig. 1. Scheme of the NADPH p22phox
gene presenting the 6 exons of the gene (E1–
E6) and their sizes in basepairs (bp). Posi-
tions are not in scale. The relative positions
of the five polymorphisms are shown termed
with the expression commonly used in the
literature (upper line) and according to the
nomenclature we refer to (lower line). In
brackets, the amino acid codes and their
position in the amino acid sequence are giv-
en. UTR = Untranslated region.
The PCR product (353 bp) was cleaved by RsaI (New England
Biolabs, Inc., Beverly, Mass., USA) in the appropriate buffer. The
enzyme does not cut wild-type DNA at that particular site. Digestion
of the PCR product yields bands of 353 bp in CC homozygotes (wild-
type), 160 and 193 bp in TT homozygotes, and all 3 bands in the
heterozygous state. Fragments were resolved by electrophoresis on
denaturing 6.5% Long Ranger gels (FMC Bioproducts, Rockland,
Me., USA) and analyzed using Fragment Manager™ (Pharmacia
Biotech, Uppsala, Sweden) software.
Sequence Analysis of Exon 6
Polymorphisms 381T1C, 480G1A, 521C1T, and *24A1G are lo-
cated in exon 6 and the 3)-UTR, respectively. Therefore, we decided
to investigate this genomic region by direct sequence analysis.
Following primers were used: 5)-GCTCAACCCTTCAGTGCC-
3) and 5)-CATTTATTGCAGGTGGGTGC-3) (Amersham Pharma-
cia Biotech, Erlangen, Germany). 1 ÌM of each primer (sense primer
was cyanine5 end-labeled) was mixed with 100 ng of genomic DNA
and 12.5 Ìl PCR Master Mix (Promega, Madison, Wisc., USA) in a
final volume of 25 Ìl.
Amplifying conditions were: initial denaturation at 95 °C for
2 min followed by 40 cycles of denaturation at 95°C for 30 s, anneal-
ing at 60°C for 30 s and extension at 72 °C for 45 s, completed by a
final extension step at 72°C for 5 min using a thermal cycler (Perkin
Elmer, Applied Biosystems GmbH). For negative control water was
used instead of genomic DNA in PCR.
PCR products were electrophoresed on a 0.8% agarose gel, and
bands were cut out and eluted. 3 Ìl of the eluted PCR product were
used in reaction mix where 1 Ìl of Thermo Sequenase Mix (Amers-
ham Pharmacia Biotech UK Ltd, Little Chalfont, UK) and 1 ÌM
cyanine5 end-labeled sense primer were added. Cycling reaction was
performed under the following conditions using a thermo cycler:
95°C for 3 min followed by 25 cycles at 95°C for 30 s and at 65°C
for 30 s, followed by 72°C for 3 min. Cycling products were run on
ALFexpress® using denaturing 6.5% Long Ranger gels, which were
run at 40 W (1,000 V, 38 mA) for 4 h. Runs were analyzed using ALF
EvaluationTM software.
Statistical Methods and Study Course
The size of the primary case sample was determined so that an
allele frequency of 10% could be detected with a confidence of 97.5%
without assuming Hardy-Weinberg equilibrium [13], thus limiting
the overall error in both groups to 5%. Hence, a primary sample of 35
cases and 28 controls was investigated.
Deviations from Hardy-Weinberg equilibrium were evaluated by
comparing observed and expected genotype frequencies with an
exact goodness of fit test in cases and controls, separately. To validate
findings, a second sample of 78 cases was enrolled to detect the same
deviation with a power of 90% at a nominal significance level of 5%.
Odds ratios (ORs) and exact 95% confidence intervals (CIs) were
calculated to compare allele frequencies [14] and genotype frequen-
cies using the Cochrane-Armitage trend test.
Furthermore, haplotypes were constructed using the expectation
maximization algorithm with subsequent haplotype testing via per-
mutation tests [15].
Nomenclature
In the current literature polymorphisms of the NADPH p22phox
gene are frequently termed according to the position of the con-
cerned nucleotide in the mRNA sequence of this gene published in
the GenBank database (http://www.ncbi.nlm.nih.gov: accession
NM_000101). We refer to the nomenclature system recommended
by den Dunnen and Antonarakis [16] and the Nomenclature Work-
ing Group 1998 (http://www.dmd.nl/mutnomen.html). In figure 1
the polymorphisms are depicted according to both nomenclatures.
Results
A total of 113 patients and 53 anonymous controls
were enrolled in this study. Patient characteristics are
summarized in table 1.
Genotype and allele frequencies of all five particular
SNPs of the p22phox gene were determined in the prima-
ry sample comprising 35 patients and 28 controls. Their
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Table 2. Allele frequencies in the primary
study sample Locus Allele Intracranial
aneurysm (n = 35)
n %
Control
(n = 28)
n %
OR (95% CI)
214C1T M 48 68.57 40 71.43 1.15 (0.50–2.67)
m 22 31.43 16 28.57
381T1C M 69 98.58 53 94.64 0.26 (0.00–3.33)
m 1 1.42 3 5.36
480G1A M 68 97.14 56 100.00 – (0.15–)
m 2 2.86 0 0.00
521C1T M 37 52.86 34 60.71 1.38 (0.64–3.00)
m 33 47.14 22 39.29
*24A1G M 44 62.86 33 58.93 0.85 (0.39–1.86)
m 26 37.14 23 41.07
M = Major, more common allele; m = minor, less common allele; OR = odds ratio; CI =
confidence interval.
Table 3. Genotype frequencies in the
primary study sample Locus Genotype Intracranial
aneurysm (n = 35)
n %
Control
(n = 28)
n %
OR (95% CI)
214C1T M/M 17 48.57 14 50.00
M/m 14 40.00 12 42.86 1.14 (0.50–2.66)
m/m 4 11.43 2 7.14 1.30(0.25–7.06)
381T1C M/M 34 97.14 25 89.29
M/m 1 2.86 3 10.71 0.25 (0.00–3.33)
m/m 0 0.00 0 00.00
480G1A M/M 34 97.14 28 100.00
M/m 0 0.00 0 0.00
m/m 1 2.86 0 0.00 – (0.02–)
521C1T M/M 13 37.14 12 42.86
M/m 11 31.43 10 35.71 1.27 (0.66–2.51)
m/m 11 31.43 6 21.43 1.62 (0.43–6.28)
*24A1G M/M 13 37.14 11 39.29
M/m 18 51.43 11 39.29 0.85 (0.39–1.84)
m/m 4 11.43 6 21.43 0.73 (0.15–3.40)
M = Major, more common allele; m = minor, less common allele; OR = odds ratio; CI =
confidence interval.
distribution in both groups and results from the compari-
sons of allele and genotype frequencies are presented in
tables 2 and 3.
No deviation from Hardy-Weinberg equilibrium was
detected at polymorphisms 214C1T and *24A1G in ei-
ther group, and at the 521C1T polymorphism in the con-
trol group (all nominal p 1 0.05). In the case group, how-
ever, Hardy-Weinberg disequilibrium was found at the
521C1T polymorphism (nominal p = 0.0399). To validate
this finding, a second sample of 78 cases was enrolled to
detect the same deviation with a power of 90% at a nomi-
nal significance level of 5%. This sample did not reveal
deviation from Hardy-Weinberg equilibrium (nominal
p 1 0.05).
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Table 4. Haplotypes constructed out of polymorphisms 214C1T,
521C1T, and *24A1G
Genotypea
214C1T 521C1T *24A1G
Cases
n %
Controls
n %
1 1 2 4 11.4 0 0.0
1 1 3 3 8.6 4 14.3
1 2 2 5 14.3 5 17.9
1 3 1 5 14.3 5 17.9
2 1 2 3 8.6 2 7.1
2 1 3 1 2.9 0 0.0
2 2 2 6 17.1 3 10.7
2 2 3 0 0.0 2 7.1
2 3 1 4 11.4 5 17.9
3 3 1 4 11.4 1 3.6
3 3 2 0 0.0 1 3.6
Total 35 28
Empirical significance level from 1,000 permutations using ¯2
statistic for model-free analysis = 11.38, df = 8, p = 0.2030 (NS).
a 1 = Major/major allele; 2 = major/minor allele; 3 = minor/minor
allele.
In addition, allele and genotype frequencies of this sec-
ond sample of cases were compared with a second sample
of controls (n = 25), which confirmed the results of the
first study sample (data not shown).
Certainly, it would have been interesting to base the
calculation of the size of a validation sample not on
detecting deviations from Hardy-Weinberg equilibrium
but on detecting differences in allele frequencies between
cases and controls calculated from the first sample. How-
ever, as the frequencies of the T allele were similar in
cases and controls (32.86 and 28.57%, respectively),
2,030 cases and 2,030 controls would have been required
to detect this difference with a power of 90%.
Haplotypes were constructed regarding the three
most frequent polymorphisms (214C1T, 521C1T, and
*24A1G) for the total sample. Genotypes and their distri-
bution between cases and controls are shown in table 4.
Haplotype frequencies in cases and controls were not sig-
nificantly different (p = 0.203).
Discussion
The NADPH oxidase system is a major source of
superoxide anion formation. Oxygen free radicals are
involved in tissue remodeling and atherogenesis, and
superoxide reaction products were detected in initial
stages of cerebral aneurysm. The genetic background of
these findings is unclear. Our aim was to investigate
whether polymorphisms of the NADPH oxidase p22phox
gene are associated with the phenotype, an intracranial
aneurysm. In our analysis, we have not found an associa-
tion of either the 214C1T polymorphism or polymor-
phisms located in and around exon 6 of the NADPH oxi-
dase p22phox gene with the occurrence of cerebral aneu-
rysms in a Caucasian population.
The NADPH oxidase system was originally described
in phagocytes [17, 18]. Recent studies provide evidence
that the NADPH oxidase is also present in nonphagocytic
cells [3, 19, 20]. p22phox is one of five proteins forming
the NADPH core enzyme, and is a critical component of
the NADPH oxidase system in VSMCs. Mutations in the
human neutrophil cytochrome b light chain (p22phox) are
associated with chronic granulomatous disease [21]. In
addition, four types of polymorphisms of the p22phox
gene have been reported and are discussed in the litera-
ture. The 214C1T polymorphism, located in exon 4 of the
p22phox gene, results in an amino acid exchange, histi-
dine-72 by tyrosine, in the heme-binding region of the
protein. The 381T1C, and 480G1A polymorphisms do
not affect amino acid sequences, while 521C1T changes
alanine to valine at codon 174, and *24A1G is located in
the 3)-UTR of the gene, 24 bp downstream of the stop
codon. The clinical significance of these polymorphisms
is controversial [8–11].
These conflicting results could be explained by ethnic-
related differences, in addition to differences in study
design, choice and size of study samples. The possible
impact of racial/ethnic differences on allele frequencies of
polymorphisms was previously shown by us, analyzing
the endoglin gene [22].
In a Japanese population, a significant correlation
between the polymorphic allele of the 214C1T polymor-
phism and CVD was reported [12]. To our knowledge,
confirmation of these results in another ethnic group has
not been published. However, the findings by Ito et al.
[12] confirm previous results by Walder et al. [23] who
reported that the extent of ischemic stroke injury is
reduced in NADPH oxidase-deficient mice. In our study,
we did not find an association between the 214C1T poly-
morphism and the occurrence of cerebral aneurysms, sug-
gesting either that this particular polymorphism has a spe-
cific disease-related meaning for CVD, or that we cannot
detect a difference between cases and controls in our
aneurysm study because of racial/ethnic differences be-
tween Japanese and Caucasian healthy individuals. In-
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deed, a comparison of genotype frequencies between our
Caucasian controls and the Japanese control group re-
ported by Ito et al. [12] revealed a difference: frequencies
for the wild-type/wild-type genotype 0.50 in our controls
vs. 0.87 in the Japanese controls (nominal exact p !
0.0001). However, it is possible that we failed to detect a
difference between cases and controls in our population,
as the power of our study was only 17% in relation to the
data of the Japanese study. To detect the difference
reported by Ito et al. [12] with a power of 90%, 370 cases
and 370 controls would have been required.
Nevertheless, our results do not exclude that this par-
ticular gene might be involved in aneurysm pathogenesis
as the effect might be smaller than in the Japanese study.
Furthermore, we only analyzed a part of the gene. In addi-
tion to p22phox, the other components of the NADPH
oxidase complex harbor genetic variants, which also
might contribute to an altered superoxide production in
the vascular wall, and thus may contribute to aneurysm
genesis.
However, we have shown that frequent polymor-
phisms of the p22phox gene located in the open reading
frame and the 3)-UTR, which have been associated with
vascular diseases, are not associated with intracranial
aneurysms in our Caucasian population.
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